Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC
- DOI
- 10.3390/cancers17050748
- Published
- 2025-02-22
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers17050748,
title = {Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC},
author = {Jürgen Wolf and Sarah Goring and Adam Lee and Byoung Chul Cho and Alexander Drilon and Yong Yuan and Dieter Ayers and Greta Lozano-Ortega and Ellen E. Korol and Sarah G. Korpach and Madeleine Crabtree and Lavanya Huria and Christophe Y. Calvet and D. Ross Camidge},
year = {2025},
journal = {Cancers},
doi = {10.3390/cancers17050748},
url = {https://doi.org/10.3390/cancers17050748}
}RIS
TY - JOUR TI - Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC AU - Jürgen Wolf AU - Sarah Goring AU - Adam Lee AU - Byoung Chul Cho AU - Alexander Drilon AU - Yong Yuan AU - Dieter Ayers AU - Greta Lozano-Ortega AU - Ellen E. Korol AU - Sarah G. Korpach AU - Madeleine Crabtree AU - Lavanya Huria AU - Christophe Y. Calvet AU - D. Ross Camidge PY - 2025 JO - Cancers DO - 10.3390/cancers17050748 UR - https://doi.org/10.3390/cancers17050748 ER -
APA
Wolf, J., Goring, S., Lee, A., Cho, B. C., Drilon, A., Yuan, Y., Ayers, D., Lozano-Ortega, G., Korol, E. E., Korpach, S. G., Crabtree, M., Huria, L., Calvet, C. Y., & Camidge, D. R. (2025). Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC. Cancers. https://doi.org/10.3390/cancers17050748
Source records
- crossref · retrieved 2026-09-25T19:54:43.044Z